Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has informed BSE that its Board of Directors will meet on Friday, 23 May 2025. The main item on the agenda is to approve and take on record the Audited Standalone Financial Results for the quarter and full year ended 31 March 2025. The notice also includes a standard agenda item allowing the Board to discuss any other matter with its permission. The filing was made on 12 May 2025 under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, which governs how companies announce board meetings that will consider financial results.
No immediate impact on shareholders — this is a routine advance notice. Investors should watch for the actual Q4 and FY25 audited results, which will be disclosed after the 23 May 2025 board meeting and may move the stock.